Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
出版年份 2022 全文链接
标题
Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
作者
关键词
-
出版物
Frontiers in Neurology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-25
DOI
10.3389/fneur.2022.748599
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tau in the Pathophysiology of Parkinson’s Disease
- (2021) Lina Pan et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Increase of Prokineticin‐2 in Serum of Patients with Parkinson's Disease
- (2021) Tommaso Schirinzi et al. MOVEMENT DISORDERS
- Young onset and late onset Parkinson’s disease exhibit a different profile of fluid biomarkers and clinical features.
- (2020) Tommaso Schirinzi et al. NEUROBIOLOGY OF AGING
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson’s Disease
- (2020) Giulia Maria Sancesario et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Systemic activation of Nrf2 pathway in Parkinson's disease
- (2019) Sara Petrillo et al. MOVEMENT DISORDERS
- Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease
- (2018) Nooshin Abbasi et al. MOVEMENT DISORDERS
- Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
- (2018) Anthony E. Lang et al. MOVEMENT DISORDERS
- White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
- (2018) Charlotte E. Teunissen et al. Alzheimers Research & Therapy
- CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients
- (2018) Tommaso Schirinzi et al. PARKINSONISM & RELATED DISORDERS
- Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer’s disease
- (2017) Tommaso Schirinzi et al. JOURNAL OF NEURAL TRANSMISSION
- Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus
- (2016) Benjamin Roeben et al. JOURNAL OF ALZHEIMERS DISEASE
- The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis: The Italian Selfie
- (2016) Giulia M. Sancesario et al. JOURNAL OF ALZHEIMERS DISEASE
- Progression of Regional Microstructural Degeneration in Parkinson’s Disease: A Multicenter Diffusion Tensor Imaging Study
- (2016) Yu Zhang et al. PLoS One
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- How many biomarkers to discriminate neurodegenerative dementia?
- (2015) Giulia M. Sancesario et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Aβ42 and Aβ40: similarities and differences
- (2015) Tian Qiu et al. JOURNAL OF PEPTIDE SCIENCE
- A Clinical and Biochemical Analysis in the Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus
- (2015) Tommaso Schirinzi et al. Frontiers in Neurology
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started